CSF2 and neoplasm: T-VEC is a modified HSV-1 virus with deletions of IC 34.5 and ICP47 that can enhance the tumor-suppression activity and safety of normal cells, and the transgene GM-CSF promotes APCs and induces systemic anti-tumor immunity.